Nanoparticles-Based Antimicrobials, 2nd Edition

A special issue of Antibiotics (ISSN 2079-6382). This special issue belongs to the section "Novel Antimicrobial Agents".

Deadline for manuscript submissions: 15 August 2024 | Viewed by 157

Special Issue Editor

E-Mail Website
Guest Editor
1. Prolepsis-Institute of Preventive Medicines Environment and Occupational, Health, Athens, Greece
2. National School of Professional Training, Volos, Greece
Interests: pharmaceutical nanotechnology; aliphatic polyesters; biopolymers; biodegradable polymers; nanotechnology
Special Issues, Collections and Topics in MDPI journals

Special Issue Information

Dear Colleagues,

We have published one successful volume of the Special Issue “Nanoparticles-Based Antimicrobials”, and this encourages us to open a second volume focused on the same topic.

As a continuation of the Special Issue published in 2021, this second volume will further seek new advances through the use of nanotechnology—and therefore new materials—in the detection and treatment of antibiotic-resistant pathogenic organisms. This will be achieved either via the targeted delivery of the drug or through the use of specific functionalized nanoparticles as a method of dealing with pathogens or targeting virulent factors.

Dr. Sofia A. Papadimitriou
Guest Editor

Manuscript Submission Information

Manuscripts should be submitted online at by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Antibiotics is an international peer-reviewed open access monthly journal published by MDPI.

Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2900 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.


  • biopolymers
  • nanoparticles
  • drug delivery
  • antimicrobials
  • targeted delivery
  • antimicrobial Resistance

Related Special Issue

Published Papers

This special issue is now open for submission, see below for planned papers.

Planned Papers

The below list represents only planned manuscripts. Some of these manuscripts have not been received by the Editorial Office yet. Papers submitted to MDPI journals are subject to peer-review.

Title: Lipid Nanoparticle-Based Formulations of Antimicrobial Peptides Studied by NMR
Authors: Soo-Yeon Lee; Ki-Young Lee
Affiliation: College of Pharmacy, CHA university, Republic of Korea
Abstract: Lipid nanoparticles have increasingly received attention as nano-formulation and nanocarrier platforms for antimicrobial peptides (AMPs). Here, we present recent studies on the mechanism and structural basis of lipid nanoparticle-AMP formulations using NMR. Lipid nanoparticles mimic cellular membranes and have many biological advantages including rapid cellular internalization, high biocompatibility, and excellent buffer stability, compared to other nanoparticles. NMR is an excellent tool to probe the structure and dynamics of nanoparticle-bound AMPs and the AMP assembly in or on nanoparticles, which will aid in design of stable nanoparticle-AMP formulations.

Back to TopTop